You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RLAY Sale Disclosure
Catinazzo Thomas · SEC Form 4 · Filed Jun 24, 2026
Sale
Calculated transaction value
$955.8K
Catinazzo Thomas Chief Financial Officer
RLAY
Relay Therapeutics
RLAY
Transaction date
Jun 22, 2026
Public filing date
Jun 24, 2026
Filing lag
Filed 2 days later
RLAY daily price context
Close on/before transaction
$17.28
Jun 22, 2026
First close after public filing
$17.83
Jun 25, 2026
30-day return after filing
+3.42%
Through Jul 24, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 56,323 shares @ $16.97
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-281061
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$4.01M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Relay Therapeutics, Inc. RLAY | Sale | Jun 22, 2026 | $301.37K |
| Relay Therapeutics, Inc. RLAY | Exercise | Jun 22, 2026 | $283.87K |
| Relay Therapeutics, Inc. RLAY Current | Sale | Jun 22, 2026 | $955.8K |
| Relay Therapeutics, Inc. RLAY | Exercise | Jun 22, 2026 | $321.36K |
| Relay Therapeutics, Inc. RLAY | Sale | Jun 22, 2026 | $1.04M |
| Relay Therapeutics, Inc. RLAY | Exercise | Jun 22, 2026 | $229.44K |
| Relay Therapeutics, Inc. RLAY | Sale | Jun 22, 2026 | $874.97K |
| Relay Therapeutics, Inc. RLAY | Exercise | Jun 22, 2026 | $0 |
| Relay Therapeutics, Inc. RLAY | Exercise | Jun 22, 2026 | $0 |
| Relay Therapeutics, Inc. RLAY | Exercise | Jun 22, 2026 | $0 |